These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neurodegenerative diseases: expanding the prion concept. Walker LC; Jucker M Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008 [TBL] [Abstract][Full Text] [Related]
6. Application of yeast to studying amyloid and prion diseases. Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA Adv Genet; 2020; 105():293-380. PubMed ID: 32560789 [TBL] [Abstract][Full Text] [Related]
7. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases? Ritchie DL; Barria MA Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845 [TBL] [Abstract][Full Text] [Related]
8. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522 [TBL] [Abstract][Full Text] [Related]
9. [Neurodegenerative conformational disease and its molecular bases]. Li WW; Cai DF; Ren HM Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610 [TBL] [Abstract][Full Text] [Related]
10. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders. Carlson GA; Prusiner SB Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393 [TBL] [Abstract][Full Text] [Related]
12. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins. Eraña H; Venegas V; Moreno J; Castilla J Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers. Ugalde CL; Finkelstein DI; Lawson VA; Hill AF J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376 [TBL] [Abstract][Full Text] [Related]
14. Prion and prion-like diseases in animals. Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937 [TBL] [Abstract][Full Text] [Related]
15. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice. Hope J; Kirby L Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360 [TBL] [Abstract][Full Text] [Related]
16. Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Rahimi F; Shanmugam A; Bitan G Curr Alzheimer Res; 2008 Jun; 5(3):319-41. PubMed ID: 18537546 [TBL] [Abstract][Full Text] [Related]
17. Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseases. Thompson AJ; Barrow CJ Curr Med Chem; 2002 Oct; 9(19):1751-62. PubMed ID: 12369885 [TBL] [Abstract][Full Text] [Related]
18. Protein aggregation as a cause for disease. Scheibel T; Buchner J Handb Exp Pharmacol; 2006; (172):199-219. PubMed ID: 16610361 [TBL] [Abstract][Full Text] [Related]
19. Protein misfolding and aggregation in ageing and disease: molecular processes and therapeutic perspectives. Tuite MF; Melki R Prion; 2007; 1(2):116-20. PubMed ID: 19164925 [TBL] [Abstract][Full Text] [Related]
20. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Moreno-Gonzalez I; Soto C Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]